These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 21449826

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Liquisolid technique to enhance and to sustain griseofulvin dissolution: effect of choice of non-volatile liquid vehicles.
    Elkordy AA, Essa EA, Dhuppad S, Jammigumpula P.
    Int J Pharm; 2012 Sep 15; 434(1-2):122-32. PubMed ID: 22677418
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices.
    Javadzadeh Y, Musaalrezaei L, Nokhodchi A.
    Int J Pharm; 2008 Oct 01; 362(1-2):102-8. PubMed ID: 18647643
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Liquisolid compacts: the effect of cosolvent and HPMC on theophylline release.
    Nokhodchi A, Aliakbar R, Desai S, Javadzadeh Y.
    Colloids Surf B Biointerfaces; 2010 Aug 01; 79(1):262-9. PubMed ID: 20451361
    [Abstract] [Full Text] [Related]

  • 8. EVALUATION OF SORPTIVE PROPERTIES OF VARIOUS CARRIERS AND COATING MATERIALS FOR LIQUISOLID SYSTEMS.
    Vraníková B, Gajdziok J.
    Acta Pol Pharm; 2015 Aug 01; 72(3):539-49. PubMed ID: 26642662
    [Abstract] [Full Text] [Related]

  • 9. In vitro release evaluation of hydrocortisone liquisolid tablets.
    Spireas S, Sadu S, Grover R.
    J Pharm Sci; 1998 Jul 01; 87(7):867-72. PubMed ID: 9649356
    [Abstract] [Full Text] [Related]

  • 10. Formulation and evaluation of liquisolid compacts for olmesartan medoxomil.
    Prajapati ST, Bulchandani HH, Patel DM, Dumaniya SK, Patel CN.
    J Drug Deliv; 2013 Jul 01; 2013():870579. PubMed ID: 24232077
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Use of biorelevant media for assessment of a poorly soluble weakly basic drug in the form of liquisolid compacts: in vitro and in vivo study.
    Badawy MA, Kamel AO, Sammour OA.
    Drug Deliv; 2016 Jul 01; 23(3):818-27. PubMed ID: 24892630
    [Abstract] [Full Text] [Related]

  • 13. Improvement of dissolution properties of Carbamazepine through application of the liquisolid tablet technique.
    Tayel SA, Soliman II, Louis D.
    Eur J Pharm Biopharm; 2008 May 01; 69(1):342-7. PubMed ID: 17949959
    [Abstract] [Full Text] [Related]

  • 14. Enhancement of dissolution rate of piroxicam using liquisolid compacts.
    Javadzadeh Y, Siahi-Shadbad MR, Barzegar-Jalali M, Nokhodchi A.
    Farmaco; 2005 Apr 01; 60(4):361-5. PubMed ID: 15848213
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Liquisolid technique for dissolution rate enhancement of a high dose water-insoluble drug (carbamazepine).
    Javadzadeh Y, Jafari-Navimipour B, Nokhodchi A.
    Int J Pharm; 2007 Aug 16; 341(1-2):26-34. PubMed ID: 17498898
    [Abstract] [Full Text] [Related]

  • 18. Effect of powder substrate on the dissolution properties of methyclothiazide liquisolid compacts.
    Spireas S, Wang T, Grover R.
    Drug Dev Ind Pharm; 1999 Feb 16; 25(2):163-8. PubMed ID: 10065349
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.